glp-1 6 in 1 oral liquid Therapy for Metabolic & Weight Health GLP-1 Liquid Drops, GLP1 Support

3 Takeaways on GLP-1s and the Future 1 | Beyond weight-loss applications to treating cardiovascular disease

GLP-1 receptor agonist meds help regulate blood glucose by stimulating insulin secretion when blood sugar levels are high and reducing glucagon release to prevent spikes

GLP-1 receptor agonists were associated with markedly lower risks of major adverse cardiovascular events, progression of kidney disease, venous thromboembolism, and all-cause mortality compared to DPP-4 inhibitor therapy

Thus, creating a void to conduct future studies to examine longer duration treatment to check their prolonged effects (98)

Future research should focus on identifying the most responsive patient subgroups, evaluating long-term safety, and exploring combination therapies to enhance metabolic and reproductive outcomes

A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus